Prednisolone
CLINICAL USE
Corticosteroid:Immunosuppression Anti-inflammatory
DOSE IN NORMAL RENAL FUNCTION
Oral: variableIM: 25–100 mg once or twice weekly (as prednisolone acetate)
PHARMACOKINETICS
Molecular weight                           :360.4 %Protein binding                           :70–95 saturable %Excreted unchanged in urine     : 11–30 Volume of distribution (L/kg)       :1.3–1.7half-life – normal/ESRD (hrs)      :2–4/Increased DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal function HDF/high flux   :Not dialysed. Dose as in normal renal function CAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntibacterials: metabolism accelerated by rifamycins; metabolism possibly inhibited by erythromycinAnticoagulants: efficacy of coumarins may be alteredAnti-epileptics: metabolism accelerated by carbamazepine, barbiturates, phenytoin and primidone Antifungals: increased risk of hypokalaemia with amphotericin – avoid concomitant use; metabolism possibly inhibited by itraconazole and ketoconazoleAntivirals: concentration possibly increased by ritonavirCiclosporin: rare reports of convulsions in patients on ciclosporin and high-dose corticosteroids; increased levels of prednisolone; increased ciclosporin levels reported with prednisoloneCytotoxics: increased risk of haematological toxicity with methotrexate Diuretics: enhanced hypokalaemic effects of acetazolamide, loop diuretics and thiazide diureticsVaccines: high dose corticosteroids can impair immune response to vaccines – avoid concomitant use with live vaccines ADMINISTRATION
Reconstition
– Route
Oral, IM, rectal Rate of Administration
–Comments
– OTHER INFORMATION
Evidence of unpredictable bioavailability from enteric coated tablets – avoid if possible.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home